OrthoNovis

Executive Summary

OrthoNovis is a privately held medical device company based in Minneapolis, founded in 2016, that designs and markets orthopedic surgical implants and trauma systems. The company positions itself as a provider of 'best in class' products at financially responsible prices, aiming to help control healthcare costs without compromising quality. Its focus on value-based care aligns with industry trends favoring cost-effective solutions. Although OrthoNovis has not disclosed funding rounds or valuation, its presence in the competitive orthopedic market suggests a niche strategy targeting mid-sized hospitals and outpatient surgery centers. The company's products likely include joint reconstruction implants, fracture fixation devices, and spinal systems, though specific portfolio details are unavailable. As a private entity, OrthoNovis operates with limited public visibility, which impacts its ability to gauge market traction or R&D progress.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for a novel trauma plating system60% success
• TBDPartnership or distribution agreement with a major hospital group40% success
• Q4 2026Series A funding round to scale manufacturing and sales50% success